Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for ischemic cardiomyopathy (Follow-up trial)

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2053220055

Enrollment

Registered

2022-06-22

Start date

2022-06-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who have undergone iPS cell derived-cardiomyocyte sheet (Clinical trial identification code:IPSOC-1) transplantation 2) Patients who can obtain concent to participate in this trial

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Lifetime	—

Secondary

Measure	Time frame
1) Number and rate of clinical events of cardiac function such as death and hospitalization 2) Number and rate of tumor development events	—

Contacts

Public ContactTakuji Kawamura

Osaka university hospital

saisentan@tissue.med.osaka-u.ac.jp+81-6-6879-3154

Outcome results